Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENDRA Life Sciences
Ann Arbor, Michigan, United Statesendrainc.com ↗
- Ownership
- Public · NDRA
- Employees
- ~21
- Development stage
- Commercial
01
Overview
TAEUS® has received CE mark approval for non-invasive liver fat measurement in Europe. Clinical studies are ongoing to support FDA clearance in the US. The technology aims to provide a cost-effective alternative to MRI or biopsy for early detection of steatotic liver disease. Early results suggest TAEUS® can quantify liver fat at the point of care with high accuracy compared to current standards. Additional clinical validation and regulatory milestones are expected through mid-to-late 2025.
No therapeutic products—ENDRA’s focus remains on diagnostic devices.
Pipeline breadth reflects one commercial program with several exploratory/early-stage programs.
- Therapeutic areas
- GastroenterologyCardiovascularMetabolic Disorders
- Modalities
- DeviceNon-pharmacological therapy (diagnostic device)
- Industry
- Medical Imaging
02
Partnerships
GE Healthcare (strategic collaboration on ultrasound technology development)
03
Financials
- Market cap
- $7.5M
- Total revenue
- $0
- Enterprise value
- $6.2M
Beyond the preview
Go deeper on ENDRA Life Sciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENDRA Life Sciences.